You may be right but I don’t think FDA wants to underestimate demand from all comers including project Orbis (expanding) off label etc and that requires a much more aggressive ramp capability. That capability is what flipper44 and I believe must be in place at or just after news which will create instant demand for availability. A breakthrough has no where to hide once news is out. Linda has done a great job of hiding until ready so as to defend against creating false patient hope when they can’t access the treatment yet. With Charles River Labs adding two new large clean room suites in their Pennsylvania facility last year with additional equipment installed to increase output for a “vaccine candidate”(sounds like a comparability test drive) I believe bears and some longs are not taking this very important aspect into full consideration. Anyway just my two copper coins worth ; ). Best wishes.
Market Data 
Markets 
AI
